Güllner H G, Gill J R, Bartter F C, Düsing R
Am J Med. 1980 Nov;69(5):718-24. doi: 10.1016/0002-9343(80)90437-4.
The role of prostaglandins in the regulation of renal function was studied in seven healthy female volunteers taking a constant metabolic diet containing 59 meq of sodium and about 50 meq of potassium daily. Each subject underwent two renal clearance studies, during which vasopressin (priming dose, 200 mU; "sustainer," 200 mU/hour at 1 ml/min) was infused intravenously. The first clearance study served as the control; indomethacin (2 mg/kg/day) was given for seven days before the second clearance study to inhibit prostaglandin synthesis. Food and fluid were withheld for 12 hours before the studies. Urine was collected through an indwelling bladder catheter at 30 minute intervals. Glomerular filtration rate was estimated from inulin clearance and renal blood flow from para-aminohippurate (PAH) clearance. Indomethacin was associated with a significant increase in maximal urinary osmolality from 826 +/- 47 mosmol/kg H2) to 920 +/- 32 mosmol/kg H2O (P < 0.01). Minimal "free water" clearance was -1.40 +/- 0.02 ml/min before and -1.63 +/- 0.04 ml/min (P < 0.01) after the administration of indomethacin. Indomethacin did not affect urine flow, urinary sodium or potassium excretion, glomerular filtration rate or renal plasma flow. In addition, indomethacin did not affect the urinary excretion of cyclic adenosine monophosphate (AMP). Plasma arginine-vasopressin, measured in two subjects by radioimmunoassay, did not change with blockade of prostaglandin synthesis. It appears that prostaglandins antagonize the hydro-osmotic effect of antidiuretic hormone by an intrarenal mechanism, independent of changes in renal hemodynamics or cation excretion. This mechanism is probably mediated by an alteration in the water permeability of the collecting ducts. Since urinary cyclic AMP did not change during blockade of prostaglandin synthesis, whereas urinary osmolality increased, a change of vasopressin-dependent cyclic AMP production in the kidney was probably not reflected in urinary cyclic AMP.
在7名健康女性志愿者中研究了前列腺素在肾功能调节中的作用,这些志愿者采用含59毫当量钠和每日约50毫当量钾的恒定代谢饮食。每位受试者进行了两项肾脏清除率研究,在此期间静脉输注血管加压素(起始剂量200 mU;“维持量”,以1 ml/min的速度200 mU/小时)。第一项清除率研究作为对照;在第二项清除率研究前7天给予吲哚美辛(2 mg/kg/天)以抑制前列腺素合成。研究前禁食禁水12小时。通过留置膀胱导管每隔30分钟收集尿液。根据菊粉清除率估算肾小球滤过率,根据对氨基马尿酸(PAH)清除率估算肾血流量。吲哚美辛使最大尿渗透压从826±47 mosmol/kg H₂O显著增加至920±32 mosmol/kg H₂O(P<0.01)。给予吲哚美辛前最小“自由水”清除率为-1.40±0.02 ml/min,给药后为-1.63±0.04 ml/min(P<0.01)。吲哚美辛不影响尿流量、尿钠或钾排泄、肾小球滤过率或肾血浆流量。此外,吲哚美辛不影响环磷酸腺苷(AMP)的尿排泄。通过放射免疫分析法在两名受试者中测量的血浆精氨酸血管加压素,在前列腺素合成受抑制时未发生变化。似乎前列腺素通过一种肾内机制拮抗抗利尿激素的水渗透效应,这一机制独立于肾血流动力学或阳离子排泄的变化。该机制可能由集合管水通透性的改变介导。由于在前列腺素合成受抑制期间尿环AMP未发生变化,而尿渗透压增加,肾脏中血管加压素依赖性环AMP生成的变化可能未反映在尿环AMP中。